SynthesisDrugs - real world outcomes2023

Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.

Philip Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.